# Comparison Between Intravenous Ondanosteron and Metclopromide Versus Ondanesteron and Dexamethasone Effects on the Prevention of Postoperative Nausea and Vomiting in Cesarean Section

> **NCT06810531** · PHASE4 · COMPLETED · sponsor: **Aiman Al-Touny** · enrollment: 108 (actual)

## Conditions studied

- Postoperative Nausea and Vomiting

## Interventions

- **DRUG:** Ondanesterone plus dexamethasone combination
- **DRUG:** ondanesterone plus metoclopramide combination

## Key facts

- **NCT ID:** NCT06810531
- **Lead sponsor:** Aiman Al-Touny
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2025-02-05
- **Primary completion:** 2025-07-01
- **Final completion:** 2025-07-01
- **Target enrollment:** 108 (ACTUAL)
- **Last updated:** 2025-07-09


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06810531

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06810531, "Comparison Between Intravenous Ondanosteron and Metclopromide Versus Ondanesteron and Dexamethasone Effects on the Prevention of Postoperative Nausea and Vomiting in Cesarean Section". Retrieved via AI Analytics 2026-06-03 from https://api.ai-analytics.org/clinical/NCT06810531. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*